Vir Biotechnology (VIR) Event Oct. 04, 2022, 12:23 UTC 41 1 comments (10% Negative) Vir Biotechnology, Inc. (VIR) Announces Delay in Administration Development Timeline Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
QuantumSi Inc (QSI) Event Oct. 04, 2022, 12:16 UTC 32 1 comments (64% Neutral) QUANTUM-SI INCORPORATED (QSI) Reports Q4 2022 Financial Results Comment Full text
Summit Plc (SMMT) Event Oct. 04, 2022, 12:02 UTC 28 1 comments (99% Neutral) Summit Therapeutics Inc. (SMMT) Announces Clinical Development Update Comment Full text
Inhibrx (INBX) Event Oct. 04, 2022, 12:02 UTC 35 1 comments (90% Positive) INHIBRX, INC. (INBX) Provides Update on markets for illustrative purposes o Comment Full text
COMPASS Pathways plc (CMPS) Event Oct. 04, 2022, 06:08 UTC 113 0 comments COMPASS Pathways to Hold Virtual Capital Market Day on 12 October 2022 Comment Full text
QuantumSi Inc (QSI) Event Oct. 04, 2022, 05:20 UTC 113 0 comments New Form 8-K for Quantum-Si Incorporated Comment Full text
QuantumSi Inc (QSI) Event Oct. 04, 2022, 05:02 UTC 108 0 comments Quantum-Si Appoints Jeff Hawkins as Chief Executive Officer Comment Full text
KemPharm Inc (KMPH) Event Oct. 04, 2022, 04:32 UTC 106 0 comments KemPharm Supports Niemann-Pick Awareness Month During October and Global Niemann-Pick Awareness Day on October 19th Comment Full text
ATAI Life Sciences (ATAI) Event Oct. 04, 2022, 04:03 UTC 108 0 comments atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day Comment Full text
Talaris Therapeutics Inc (TALS) Event Oct. 04, 2022, 04:03 UTC 110 0 comments Talaris Therapeutics to Present at the 2022 Cell & Gene Meeting on the Mesa Comment Full text